SCHEMBL14553370

SCHEMBL14553370

COc1ccc(Oc2c(C)cc(CCC(=O)O)cc2C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 7/20 0.55
PCNA P12004 2/20 0.55
THRA P10827 3/20 0.49
THRB P10828 3/20 0.49
POLB P06746 2/20 0.49
MAPK1 P28482 1/20 0.49
HIF1A Q16665 1/20 0.49
HTT P42858 1/20 0.48
LDHA P00338 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
F2RL1 P55085 1/20 0.46
FFAR4 Q5NUL3 1/20 0.45
DGAT1 O75907 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27986391 0.90 F2RL1 (0.55) FFAR1PCNAPOLBLDHANPC1
SCHEMBL14485250 0.88 PCNA (0.70) FFAR1PCNATHRATHRBPOLB
SCHEMBL14553379 0.87 F2RL1 (0.49) PCNAPOLBHTTF2RL1ALDH1A1
SCHEMBL3669296 0.84 NPSR1 (0.52) FFAR1THRATHRBFFAR4ALDH1A1
SCHEMBL14485308 0.84 PCNA (0.77) FFAR1PCNATHRATHRBPOLB
SCHEMBL5859480 0.84 THRA (0.64) FFAR1PCNATHRATHRBPOLB
SCHEMBL18463870 0.83 THRA (0.60) FFAR1PCNATHRATHRBPOLB
SCHEMBL21942034 0.81 PCNA (0.49) FFAR1PCNATHRATHRBPOLB
SCHEMBL14905550 0.80 PCNA (0.62) FFAR1PCNATHRATHRBPOLB
SCHEMBL19663420 0.80 PCNA (0.82) FFAR1PCNATHRATHRBPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 US disclosed
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 US disclosed
WO-2013006734-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2013-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY MKI67, PCNA, PCLAF FFAR1 3290/4885PCNA 2/4885THRA 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.